Have a personal or library account? Click to login
Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells Cover

Pixantrone, a new anticancer drug with the same old cardiac problems? An in vitro study with differentiated and non-differentiated H9c2 cells

Interdisciplinary Toxicology
Volume 11 (2018): Issue 1 (May 2018)
By: Ana Reis-Mendes,  Marisa Alves,  Félix Carvalho,  Fernando Remião,  Maria Lourdes Bastos and  Vera Marisa Costa  
Open Access
|Aug 2018

Authors

Ana Reis-Mendes

Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal

Marisa Alves

Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal

Félix Carvalho

Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal

Fernando Remião

Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal

Maria Lourdes Bastos

Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal

Vera Marisa Costa

veramcosta@ff.up.pt

Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Porto, Portugal
DOI: https://doi.org/10.2478/intox-2018-0002 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Journal RSS Feed
Language: English
Page range: 13 - 21
Submitted on: Feb 2, 2018
Accepted on: May 14, 2018
Published on: Aug 6, 2018
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Pixantrone,
H9c2 cells,
cardiotoxicity
Related subjects:
Medicine,
Clinical medicine,
Pharmacology, toxicology

© 2018 Ana Reis-Mendes, Marisa Alves, Félix Carvalho, Fernando Remião, Maria Lourdes Bastos, Vera Marisa Costa, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 11 (2018): Issue 1 (May 2018)Next article